Literature DB >> 19486601

Formation of 5alpha-reduced androgens in the testes and urogenital tract of the grey short-tailed opossum, Monodelphis domestica.

Jean D Wilson1, Marilyn B Renfree, Richard J Auchus, Andrew J Pask, Geoffrey Shaw.   

Abstract

Testicular 5alpha-reduced androgens, largely 5alpha-androstane-3alpha,17beta-diol (androstanediol), are responsible for virilisation of pouch young in one marsupial (the tammar wallaby), but are not formed until later in development in another marsupial (the brushtail possum) and in rodents. Because the mechanism of virilisation of the urogenital tract in the grey short-tailed opossum Monodelphis domestica has never been defined, androgen formation and metabolism were investigated in this species. Testis fragments from grey short-tailed opossums of a wide range of ages were incubated with [3H]-progesterone and the metabolites were separated by high-performance liquid chromatography (HPLC). The only 19-carbon metabolites identified in the youngest ages (5-26 days) and the major metabolites in adult testes were testosterone and androstenedione. At 30, 42 and 49 days of age, dihydrotestosterone and small amounts of androstanediol were present. Time-sequence studies indicated that dihydrotestosterone and androstanediol were formed from the 5alpha-reduction (and 3-keto reduction) of testosterone. In a second series of experiments, tissue fragments of a variety of urogenital tract tissues were incubated with [3H]-testosterone and the metabolites separated by HPLC. During the interval in which male urogenital tract differentiation takes place in this species (between Days 15 and 28), the major metabolite identified was dihydrotestosterone. We conclude that the timing of 5alpha-reductase expression in the testes of the grey short-tailed possum resembles that of rodents and the brushtail possum rather than that of the tammar wallaby and that dihydrotestosterone is probably the intracellular androgen responsible for virilisation of the urogenital tract in this species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486601     DOI: 10.1071/RD08253

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  4 in total

1.  Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial.

Authors:  Shalender Bhasin; Thomas G Travison; Thomas W Storer; Kishore Lakshman; Manas Kaushik; Norman A Mazer; Ahn-Hoa Ngyuen; Maithili N Davda; Hernan Jara; Adam Aakil; Stephan Anderson; Philip E Knapp; Samson Hanka; Nurahmed Mohammed; Pierre Daou; Renee Miciek; Jagadish Ulloor; Anqi Zhang; Brad Brooks; Katie Orwoll; Leife Hede-Brierley; Richard Eder; Ayan Elmi; Geeta Bhasin; Lauren Collins; Ravinder Singh; Shehzad Basaria
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

Review 2.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

3.  Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.

Authors:  Christopher M Jones; Ashwini Mallappa; Nicole Reisch; Nikolaos Nikolaou; Nils Krone; Beverly A Hughes; Donna M O'Neil; Martin J Whitaker; Jeremy W Tomlinson; Karl-Heinz Storbeck; Deborah P Merke; Richard J Ross; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

4.  Alternative pathway androgen biosynthesis and human fetal female virilization.

Authors:  Nicole Reisch; Angela E Taylor; Edson F Nogueira; Daniel J Asby; Vivek Dhir; Andrew Berry; Nils Krone; Richard J Auchus; Cedric H L Shackleton; Neil A Hanley; Wiebke Arlt
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.